New Results
Activation of the urotensin-II receptor by anti-COVID-19 drug remdesivir induces cardiomyocyte dysfunction
Akiko Ogawa, Seiya Ohira, Tatsuya Ikuta, Yuri Kato, Shota Yanagida, Yukina Ishii, Yasunari Kanda, Motohiro Nishida, Asuka Inoue, Fan-Yan Wei
doi: https://doi.org/10.1101/2022.08.08.503256
Akiko Ogawa
1Department of Modomics Biology and Medicine, Institute of Development, Aging and Cancer (IDAC), Tohoku University; Sendai, Miyagi, 980-8575, Japan.
Seiya Ohira
1Department of Modomics Biology and Medicine, Institute of Development, Aging and Cancer (IDAC), Tohoku University; Sendai, Miyagi, 980-8575, Japan.
Tatsuya Ikuta
2Laboratory of Molecular & Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
Yuri Kato
3Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Shota Yanagida
4Division of Pharmacology, National Institute of Health Sciences, Kanagawa 210-9501, Japan.
5Division of Pharmaceutical Sciences, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8530, Japan.
Yukina Ishii
3Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Yasunari Kanda
4Division of Pharmacology, National Institute of Health Sciences, Kanagawa 210-9501, Japan.
Motohiro Nishida
3Department of Physiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
6National Institute for Physiological Sciences and Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences, Okazaki, Japan.
Asuka Inoue
2Laboratory of Molecular & Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3, Aoba, Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
Fan-Yan Wei
1Department of Modomics Biology and Medicine, Institute of Development, Aging and Cancer (IDAC), Tohoku University; Sendai, Miyagi, 980-8575, Japan.

- Data file S1[supplements/503256_file02.xlsx]
- Data file S2[supplements/503256_file03.xlsx]
- Data file S3[supplements/503256_file04.xlsx]
- Data file S4[supplements/503256_file05.xlsx]
Posted August 09, 2022.
Activation of the urotensin-II receptor by anti-COVID-19 drug remdesivir induces cardiomyocyte dysfunction
Akiko Ogawa, Seiya Ohira, Tatsuya Ikuta, Yuri Kato, Shota Yanagida, Yukina Ishii, Yasunari Kanda, Motohiro Nishida, Asuka Inoue, Fan-Yan Wei
bioRxiv 2022.08.08.503256; doi: https://doi.org/10.1101/2022.08.08.503256
Activation of the urotensin-II receptor by anti-COVID-19 drug remdesivir induces cardiomyocyte dysfunction
Akiko Ogawa, Seiya Ohira, Tatsuya Ikuta, Yuri Kato, Shota Yanagida, Yukina Ishii, Yasunari Kanda, Motohiro Nishida, Asuka Inoue, Fan-Yan Wei
bioRxiv 2022.08.08.503256; doi: https://doi.org/10.1101/2022.08.08.503256
Subject Area
Subject Areas
- Biochemistry (8750)
- Bioengineering (6467)
- Bioinformatics (23314)
- Biophysics (11718)
- Cancer Biology (9133)
- Cell Biology (13227)
- Clinical Trials (138)
- Developmental Biology (7403)
- Ecology (11359)
- Epidemiology (2066)
- Evolutionary Biology (15076)
- Genetics (10390)
- Genomics (14000)
- Immunology (9109)
- Microbiology (22025)
- Molecular Biology (8772)
- Neuroscience (47312)
- Paleontology (350)
- Pathology (1418)
- Pharmacology and Toxicology (2480)
- Physiology (3701)
- Plant Biology (8043)
- Synthetic Biology (2206)
- Systems Biology (6009)
- Zoology (1247)